DLH Holdings Corp. (NASDAQ:DLHC)
| Market Cap | $43.48M-48.3% |
| Revenue (ttm) | $253.54M-29.5% |
| Net Income | -$21.57M-571.2% |
| EPS | -$1.51-574.6% |
| Shares Out | 14.49M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 38,273 |
| Open | $3.20 |
| Previous Close | $3.28 |
| Day's Range | $3.00 - $3.21 |
| 52-Week Range | $3.00 - $6.88 |
| Beta | 1.42 |
| Analysts | Buy |
| Price Target | n/a |
| Earnings Date | Dec 9, 2026 |
About DLHC
DLH Holdings Corp., headquartered in Atlanta, Georgia, was established in 1969 and operated as TeamStaff, Inc. until its name change in June 2012. The company specializes in offering a range of technology-enabled business process outsourcing, comprehensive program management solutions, and public health research and analytics services throughout the United States, with a primary focus on the federal health services market. A significant portion of DLH's work involves defense and veterans' health, where it delivers integrated healthcare, technology, and logistical support. Key clients in this sector include the Department of Veterans Affairs (VA), the Defense Health Agency, the Tele-medicine and Advanced Technology Research Center, the Navy Bureau of Medicine and Surgery, and the Army Medical Research and Material Command. Additionally, the company provides diverse human services and solutions, covering areas such as rigorous monitoring and evaluation, efficient electronic medical records migration, robust data collection and management, and thorough nutritional and social health assessments. It also offers expert IT system architecture design, strategic migration planning, and continuous maintenance services. In the sphere of public health and life sciences, DLH undertakes crucial initiatives like clinical trials, epidemiological studies, and disease prevention. It actively promotes health among underserved and at-risk communities through the creation of impactful strategic communication campaigns, research into emerging health trends, in-depth health informatics analyses, and the application of proven best practices.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Next catalysts
- Dec 9, 2026Earnings report
$DLHC stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in DLHC holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by DLHC's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
DLHC Estimated quarterly lobbying spending
Source: U.S. Senate LDA
DLHC Revenue by Segment
| Prime Contractor | $38.80M | 43.83% |
| Firm Fixed Price | $21.94M | 24.78% |
| Cost Reimbursable | $14.60M | 16.49% |
| Time and Materials | $7.69M | 8.68% |
| Subcontractor | $5.43M | 6.13% |
| Other | $70.00K | 0.08% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New DLHC patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to DLHC from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in DLHC
| VTIVanguard Morningstar Total Stock Market ETF | $850.03K |
| VXFVanguard Extended Market ETF | $487.86K |
| DFATDimensional - US Targeted Value ETF | $252.07K |
| IWCiShares Micro-Cap ETF | $144.66K |
| DFSVU.S. Small Cap Value Portfolio ETF Class Shares | $88.19K |
| DFACDimensional - US Core Equity 2 ETF | $68.38K |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from DLHC’s recent data — informational, not investment advice
What’s Behind the Score
Recent Insider Activity
Insider Score Trend Over Time
-35.0 since Aug 21Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.
